Product

Therapeutic area

Indication

Status

More information

Orphacol®

Cholic acid

Digestive system diseases, metabolism, inborn errors

Treatment of inborn errors in primary bile acid synthesis due to deficiencies in:
  • 3β-hydroxy-Δ5-C27-steroid oxidoreductase
  • Δ4-3-oxosteroid-5β-reductase
in infants, children and adolescents aged 1 month to 18 years and adults

Marketed
EU MA Sept 2013

Neofordex®

Dexamethasone tablet

Haematology

Treatment of symptomatic multiple myeloma in adults in combination with other agents

Marketed
EU MA Mar 2016

CareMin 650™

Medical device

By

Oncology

Treatment of radio- or chemo-induced mucositis and dermatitis

Marketed
CE mark Feb 2020

CTRS-CC1

Dermatology

Treatment of Olmsted syndrome (palmoplantar keratoderma)

Clinical stage

CTRS-CC2

Fertility

Increased probability of success in In Vitro Fertilisation (IVF)

Clinical stage

Dexliq®

Dexamethasone solution

Oncology

 Included treatment of symptomatic multiple myeloma in combinaition with other medicinal products

On going
MAs 2018

Product

Orphacol®

Cholic acid

Therapeutic area

Digestive system diseases, metabolism, inborn errors

Indication

Treatment of inborn errors in primary bile acid synthesis due to deficiencies in:
  • 3β-hydroxy-Δ5-C27-steroid oxidoreductase
  • Δ4-3-oxosteroid-5β-reductase
in infants, children and adolescents aged 1 month to 18 years and adults

Status

Marketed
EU MA Sept 2013

More information

Product

Neofordex®

Dexamethasone tablet

Therapeutic area

Haematology

Indication

Treatment of symptomatic multiple myeloma in adults in combination with other agents

Status

Marketed
EU MA Mar 2016

More information

Product

CareMin 650™

Medical device

By

Therapeutic area

Oncology

Indication

Treatment of radio- or chemo-induced mucositis and dermatitis

Status

Marketed
CE mark Feb 2020

More information

Product

CTRS-CC1

Therapeutic area

Dermatology

Indication

Treatment of Olmsted syndrome (palmoplantar keratoderma)

Status

Clinical stage

More information

Product

CTRS-CC2

Therapeutic area

Fertility

Indication

Increased probability of success in In Vitro Fertilisation (IVF)

Status

Clinical stage

More information

Product

Dexliq®

Dexamethasone solution

Therapeutic area

Oncology

Indication

 Included treatment of symptomatic multiple myeloma in combinaition with other medicinal products

Status

On going
MAs 2018

More information

For product information

To report adverse reaction

This medicinal product is subject to additional monitoring.

Orphacol®

Cholic acid

Treatment of inborn errors in primary bile acid synthesis due to deficiencies in:
  • 3β-hydroxy-Δ5-C27-steroid oxidoreductase
  • Δ4-3-oxosteroid-5β-reductase
in infants, children and adolescents aged 1 month to 18 years and adults

Capsule containing 50 mg of cholic acid in packs of 30
Capsule containing 250 mg of cholic acid in packs of 30

Neofordex®

Dexamethasone

Neofordex is indicated in adults for the treatment of symptomatic multiple myeloma in combination with other medicinal products.

Previously called Neodex® (when it had a Temporary Utilisation Authorisation)
Tablet containing 40 mg dexamethasone in packs of 10

CareMin 650™

Medical device

In partnership with

Treatment of radio- or chemo-induced mucositis and dermatitis